Protein Degradation Series 2007
DOI: 10.1002/9783527619320.ch7b
|View full text |Cite
|
Sign up to set email alerts
|

p97 and Ubiquitin: A Complex Story

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 162 publications
0
1
0
Order By: Relevance
“…In patients with metachronous metastases from colorectal cancer, p27 was found to be down-regulated in the metastatic tumor cells compared with the primary tumors, a phenomenon not seen in metastatic colorectal disease diagnosed at the same time (synchronous) with the primary tumors, where p27 expression was low in both primary and metastatic sites [86]. p27 down-regulation in metachronous colorectal metastases was due to spindle disassembly and post-mitotic membrane fusion [93][94][95][96][97]. In colorectal carcinoma patients whose tumors showed high p97 expression were found to have statistically significantly higher probability of distant metastases development and lower disease free and overall survival compared with patients whose tumors showed low p97 expression by immunohistochemistry [98].…”
Section: Accepted Manuscriptmentioning
confidence: 90%
“…In patients with metachronous metastases from colorectal cancer, p27 was found to be down-regulated in the metastatic tumor cells compared with the primary tumors, a phenomenon not seen in metastatic colorectal disease diagnosed at the same time (synchronous) with the primary tumors, where p27 expression was low in both primary and metastatic sites [86]. p27 down-regulation in metachronous colorectal metastases was due to spindle disassembly and post-mitotic membrane fusion [93][94][95][96][97]. In colorectal carcinoma patients whose tumors showed high p97 expression were found to have statistically significantly higher probability of distant metastases development and lower disease free and overall survival compared with patients whose tumors showed low p97 expression by immunohistochemistry [98].…”
Section: Accepted Manuscriptmentioning
confidence: 90%